The company understands research applications and can offer guidance on storage, handling and experimental considerations to improve research results
Evidence Boundary Common current format, but FDA noted no published human pharmacokinetic study has formally characterized subcutaneous AOD-9604
The real magic is how they work together
It plays a role in fat metabolism and potential applications in metabolic research
In mouse models of insulin resistance, it significantly inhibits NNMT activity in liver and muscle, reduces NAM methylation, increases intracellular NAD+, activates the SIRT1 pathway, promotes phosphorylation of insulin receptor substrate 1 (IRS1), enhances insulin signaling, improves insulin sensitivity, and increases glucose uptake and utilization
Full trial-reported timeline by phase and use case